Streetbeat News

Stock Prices

BETS

BHIL

CHSN

ISPR

OTLY

PAVS

SDOT

SHOT

WBUY

XXII

ZIVO

In Thursday's intraday session, several consumer staples stocks experienced significant movements. Safety Shot (SHOT) saw a 21.5% increase, while Oatly Group (OTLY) rose by 18.61%. Zivo Bioscience (ZIVO) increased by 16.42% following its Q3 earnings report 3 days ago. Chanson International (CHSN) and Webuy Global (WBUY) also saw gains of 15.72% and 15.36%, respectively. Paranovus Enter (PAVS) stock went up by 11.91%. On the losing side, Sadot Group (SDOT) dropped by 14.6% after its Q3 earnings 2 days ago, Ispire Technology (ISPR) fell by 13.11% post Q1 earnings, 22nd Century Group (XXII) declined by 11.24%, Benson Hill (BHIL) decreased by 10.35%, and Bit Brother (BETS) fell by 9.64%.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 5:31 pm

ARCO

CZOO

FFIE

JWEL

LAZR

LVLU

MGOL

PLCE

SONO

UTI

VLCN

XWEL

In Thursday's intraday session, several consumer discretionary stocks experienced significant movements. Sonos (SONO) and Universal Technical (UTI) reported Q4 earnings, with SONO shares rising 17% and UTI shares increasing by 13%. Jowell Global (JWEL), Lulus Fashion Lounge (LVLU), XWELL (XWEL), and Arcos Dorados Holdings (ARCO) also saw gains, with JWEL's trading volume notably at 7465.2% of its average. Conversely, Volcon (VLCN), Children's Place (PLCE), Faraday Future (FFIE), Cazoo Gr (CZOO), MGO Global (MGOL), and Luminar Technologies (LAZR) stocks declined, with VLCN dropping 64.4% and PLCE's Q3 earnings report contributing to a 26.27% decrease.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 5:31 pm

APYX

AUGX

BBLG

DRMA

FIXX

IMPL

ITRM

LMDX

MEIP

PXMD

SABS

SYRA

Health care stocks experienced significant movement in Thursday's intraday session. LumiraDx (LMDX) saw a 42.8% increase, while Homology Medicines (FIXX) dropped 39.9%. Other notable gainers include Bone Biologics (BBLG), Impel Pharmaceuticals (IMPL), Iterum Therapeutics (ITRM), Apyx Medical (APYX), and Dermata Therapeutics (DRMA). On the losing side, MEI Pharma (MEIP), Augmedix (AUGX), SAB Biotherapeutics (SABS), PaxMedica (PXMD), and Syra Health (SYRA) saw declines. Volume spikes suggest increased investor interest, potentially due to recent Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 5:31 pm

AIRE

ATGL

CPTN

EBIX

EGIO

LCFY

MAXN

NICE

SASI

SNCR

VNET

WAVD

In Thursday's intraday session, several IT stocks experienced significant movements. Alpha Technology Group (ATGL) saw a 70.5% increase, while WaveDancer (WAVD) jumped 58.86%, both on high trading volumes. ReAlpha Tech Corp (AIRE), Locafy (LCFY), NICE (NICE), and Synchronoss Technologies (SNCR) also gained. Conversely, Sigma Additive Solutions (SASI), VNET Gr (VNET), Ebix (EBIX), Cepton (CPTN), Edgio (EGIO), and Maxeon Solar Technologies (MAXN) faced declines, with some linked to recent Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 5:30 pm

TMUS

Over the past 10 years, T-Mobile US (NASDAQ:TMUS) has produced an average annual return of 18.78%, outperforming the market by 9.12% on an annualized basis. A $100 investment in TMUS a decade ago would be worth $564.73 today. T-Mobile US currently has a market capitalization of $172.33 billion.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 5:30 pm

ELV

Elevance Health (NYSE:ELV) has delivered an average annual return of 19.95% over the past 15 years, outperforming the market by 7.71% on an annualized basis. A $1000 investment in ELV 15 years ago would be worth $15,634.51 today. Elevance Health currently has a market cap of $108.15 billion.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 5:30 pm

SWTX

SpringWorks Therapeutics Inc (NASDAQ:SWTX) reported positive Phase 2b ReNeu trial results for mirdametinib in treating NF1-associated plexiform neurofibromas, with over 50% pediatric and 41% adult patients showing objective responses. Despite the promising results, SWTX shares fell 6.39% to $20.66, as the market reaction was not favorable. The company plans to submit a New Drug Application to the FDA in the first half of 2024.

Portfolio Pulse from Vandana Singh

November 16, 2023 | 5:30 pm

BrightView Holdings, Inc. shares have declined following the announcement of their fourth-quarter results, which fell short of market expectations.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 5:28 pm

AAP

Advance Auto Parts, Inc. (NYSE:AAP) stock was downgraded by BofA Securities analyst Elizabeth L. Suzuki to Underperform from Neutral with a price target cut to $43 from $60. The downgrade follows AAP's Q3 earnings miss and lowered FY23 EPS outlook. The company also announced the initiation of sale processes for Worldpac and its Canada business. Other analysts from JP Morgan, Wedbush, and Goldman Sachs also lowered their price targets for AAP. AAP shares dropped 5.89% to $52.38.

Portfolio Pulse from Lekha Gupta

November 16, 2023 | 5:27 pm

IPWR

Benchmark analyst David Williams has reiterated a Buy rating on Ideal Power (NASDAQ:IPWR) and maintained the $18 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 5:26 pm